Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers.
Veelken R, Maiwald B, Strocka S, Petersen TO, Moche M, Ebel S, Denecke T, Rehak M, Struck MF, Forstmeyer D, Rademacher S, Seehofer D, Berg T, van Bömmel F.
Veelken R, et al. Among authors: maiwald b.
Cardiovasc Intervent Radiol. 2022 Feb;45(2):218-222. doi: 10.1007/s00270-021-02983-2. Epub 2021 Oct 29.
Cardiovasc Intervent Radiol. 2022.
PMID: 34716470
Free PMC article.